Uvax Bio Announces Dosing of First Participant in Phase 1 Clinical Trial Evaluating Two Vaccines to Prevent HIV-1 Infection.
January 30, 2024 at 9:00 AM

Let's talk
We would love to hear from you!
Get in touch